Dr Vanessa Cowton

  • Investigator Scientist (Virology)

telephone: 01413304637
email: Vanessa.Cowton@glasgow.ac.uk

Centre for Virus Research, 464 Bearsden Rd, Glasgow, G61 1qh

Import to contacts

Research interests

CVR logo 

Member of the Patel Group.

Publications

List by: Type | Date

Jump to: 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015
Number of items: 22.

2025

Reuss, Dorothee, Brown, Jonathan C., Sukhova, Ksenia, Furnon, Wilhelm ORCID logoORCID: https://orcid.org/0000-0002-5588-4232, Cowton, Vanessa, Patel, Arvind H. ORCID logoORCID: https://orcid.org/0000-0003-4600-2047, Palmarini, Massimo ORCID logoORCID: https://orcid.org/0000-0001-7007-4070, Thompson, Catherine and Barclay, Wendy S. (2025) Interference between SARS-CoV-2 and influenza B virus during coinfection is mediated by induction of specific interferon responses in the lung epithelium. Virology, 608, 110556. (doi: 10.1016/j.virol.2025.110556)

Zhou, J. et al. (2025) SARS-CoV-2 variants retain high airborne transmissibility by different strategies. npj Viruses, 3(1), 39. (doi: 10.1038/s44298-025-00120-1) (PMID:40312424)

2024

Ogger, P. P. et al. (2024) SARS-CoV-2 strains bearing Omicron BA.1 spike replicate in C57BL/6 mice. Frontiers in Immunology, 15, 1383612. (doi: 10.3389/fimmu.2024.1383612) (PMID:38742107) (PMCID:PMC11089223)

Furnon, Wilhelm ORCID logoORCID: https://orcid.org/0000-0002-5588-4232, Cowton, Vanessa, De Lorenzo, Giuditta ORCID logoORCID: https://orcid.org/0000-0002-2736-8740, Patel, Arvind ORCID logoORCID: https://orcid.org/0000-0003-4600-2047 and Palmarini, Massimo ORCID logoORCID: https://orcid.org/0000-0001-7007-4070 (2024) Evolution of enhanced innate immune suppression by SARS-CoV-2 Omicron subvariants. Nature Microbiology, 9, pp. 451-463. (doi: 10.1038/s41564-023-01588-4) (PMID:38228858) (PMCID:PMC10847042)

2023

Meehan, G. R. et al. (2023) Phenotyping the virulence of SARS-CoV-2 variants in hamsters by digital pathology and machine learning. PLoS Pathogens, 19(11), e1011589. (doi: 10.1371/journal.ppat.1011589) (PMID:37934791) (PMCID:PMC10656012)

Bouhaddou, M. et al. (2023) SARS-CoV-2 variants evolve convergent strategies to remodel the host response. Cell, 186(21), pp. 4597-4614. (doi: 10.1016/j.cell.2023.08.026) (PMID:37738970) (PMCID:PMC10604369)

2022

Lista, M. J. et al. (2022) The P681H mutation in the spike glycoprotein of the alpha variant of SARS-CoV-2 escapes IFITM restriction and is necessary for type I interferon resistance. Journal of Virology, 96(23), e0125022. (doi: 10.1128/jvi.01250-22) (PMID:36350154) (PMCID:PMC9749455)

Willett, B. J. et al. (2022) Publisher Correction: SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway. Nature Microbiology, 7, 1709. (doi: 10.1038/s41564-022-01241-6) (PMID:36114232) (PMCID:PMC9483304)

Willett, B. J. et al. (2022) SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway. Nature Microbiology, 7(8), pp. 1161-1179. (doi: 10.1038/s41564-022-01143-7) (PMID:35798890) (PMCID:PMC9352574)

Cowton, Vanessa M., Dunlop, James I., Cole, Sarah J., Swann, Rachael E. ORCID logoORCID: https://orcid.org/0000-0002-3945-2253 and Patel, Arvind H. ORCID logoORCID: https://orcid.org/0000-0003-4600-2047 (2022) The neutralizing antibody responses of individuals that spontaneously resolve hepatitis C virus infection. Viruses, 14(7), 1391. (doi: 10.3390/v14071391) (PMID:35891372) (PMCID:PMC9318067)

Zhou, J. et al. (2022) Mutations that adapt SARS-CoV-2 to mink or ferret do not increase fitness in the human airway. Cell Reports, 38(6), 110344. (doi: 10.1016/j.celrep.2022.110344) (PMID:35093235) (PMCID:PMC8768428)

Salas, J. H. et al. (2022) An antigenically diverse, representative panel of envelope glycoproteins for HCV vaccine development. Gastroenterology, 162(2), pp. 562-574. (doi: 10.1053/j.gastro.2021.10.005) (PMID:34655573) (PMCID:PMC8792218)

2021

Meuleman, Theodorus J., Cowton, Vanessa M., Patel, Arvind H. ORCID logoORCID: https://orcid.org/0000-0003-4600-2047 and Liskamp, Robert M.J. ORCID logoORCID: https://orcid.org/0000-0001-8897-8975 (2021) Design and synthesis of HCV-E2 glycoprotein epitope mimics in the molecular construction of potential as synthetic vaccines. Viruses, 13(2), 326. (doi: 10.3390/v13020326) (PMID:33672697) (PMCID:PMC7924389)

Rihn, S. J. et al. (2021) A plasmid DNA-launched SARS-CoV-2 reverse genetics system and coronavirus toolkit for COVID-19 research. PLoS Biology, 19(2), e3001091. (doi: 10.1371/journal.pbio.3001091) (PMID:33630831) (PMCID:PMC7906417)

Cowton, V. M. et al. (2021) Development of a structural epitope mimic: an idiotypic approach to HCV vaccine design. npj Vaccines, 6, 7. (doi: 10.1038/s41541-020-00269-1) (PMID:33420102) (PMCID:PMC7794244)

2020

Meuleman, Theodorus J., Cowton, Vanessa M., Patel, Arvind H. ORCID logoORCID: https://orcid.org/0000-0003-4600-2047 and Liskamp, Rob M.J. ORCID logoORCID: https://orcid.org/0000-0001-8897-8975 (2020) Improving the aqueous solubility of HCV-E2 glycoprotein epitope mimics by cyclization using polar hinges. Journal of Peptide Science, 26(1), e3222. (doi: 10.1002/psc.3222) (PMID:31984607)

2019

Ansari, M. A. et al. (2019) Interferon lambda 4 impacts the genetic diversity of hepatitis C virus. eLife, 8, e42463. (doi: 10.7554/eLife.42463) (PMID:31478835) (PMCID:PMC6721795)

2018

Cowton, Vanessa M., Singer, Joshua B., Gifford, Robert J. ORCID logoORCID: https://orcid.org/0000-0003-4028-9884 and Patel, Arvind H. ORCID logoORCID: https://orcid.org/0000-0003-4600-2047 (2018) Predicting the effectiveness of hepatitis C virus neutralizing antibodies by bioinformatic analysis of conserved epitope residues using public sequence data. Frontiers in Immunology, 9, 1470. (doi: 10.3389/fimmu.2018.01470) (PMID:30013555) (PMCID:PMC6036255)

2017

Naiyer, M. M. et al. (2017) KIR2DS2 recognizes conserved peptides derived from viral helicases in the context of HLA-C. Science Immunology, 2(15), eaal5296. (doi: 10.1126/sciimmunol.aal5296) (PMID:28916719)

2016

Cowton, Vanessa M., Angus, Allan G.N., Cole, Sarah J., Markopoulou, Christina K., Owsianka, Ania, Dunlop, James I., Gardner, Deborah, Krey, Thomas and Patel, Arvind H. ORCID logoORCID: https://orcid.org/0000-0003-4600-2047 (2016) Role of conserved E2 residue W420 in receptor binding and hepatitis C virus infection. Journal of Virology, 90(16), pp. 7456-7468. (doi: 10.1128/JVI.00685-16) (PMID:27279607) (PMCID:PMC4984626)

Swann, Rachael E. ORCID logoORCID: https://orcid.org/0000-0002-3945-2253, Cowton, Vanessa M., Robinson, Mark W., Cole, Sarah J., Barclay, Stephen T., Mills, Peter R., Thomson, Emma C. ORCID logoORCID: https://orcid.org/0000-0003-1482-0889, McLauchlan, John ORCID logoORCID: https://orcid.org/0000-0003-2217-9948 and Patel, Arvind ORCID logoORCID: https://orcid.org/0000-0003-4600-2047 (2016) Broad anti-hepatitis C virus (HCV) antibody responses are associated with improved clinical disease parameters in chronic HCV infection. Journal of Virology, 90(9), pp. 4530-4543. (doi: 10.1128/JVI.02669-15) (PMID:26912610) (PMCID:PMC4836347)

2015

Dunlop, James, Owsianka, Anna, Cowton, Vanessa and Patel, Arvind ORCID logoORCID: https://orcid.org/0000-0003-4600-2047 (2015) Current and future prophylactic vaccines for hepatitis C virus. Vaccine: Development and Therapy, 2015(5), pp. 31-44. (doi: 10.2147/VDT.S48437)

This list was generated on Mon Jun 16 02:04:53 2025 BST.
Jump to: Articles
Number of items: 22.

Articles

Reuss, Dorothee, Brown, Jonathan C., Sukhova, Ksenia, Furnon, Wilhelm ORCID logoORCID: https://orcid.org/0000-0002-5588-4232, Cowton, Vanessa, Patel, Arvind H. ORCID logoORCID: https://orcid.org/0000-0003-4600-2047, Palmarini, Massimo ORCID logoORCID: https://orcid.org/0000-0001-7007-4070, Thompson, Catherine and Barclay, Wendy S. (2025) Interference between SARS-CoV-2 and influenza B virus during coinfection is mediated by induction of specific interferon responses in the lung epithelium. Virology, 608, 110556. (doi: 10.1016/j.virol.2025.110556)

Zhou, J. et al. (2025) SARS-CoV-2 variants retain high airborne transmissibility by different strategies. npj Viruses, 3(1), 39. (doi: 10.1038/s44298-025-00120-1) (PMID:40312424)

Ogger, P. P. et al. (2024) SARS-CoV-2 strains bearing Omicron BA.1 spike replicate in C57BL/6 mice. Frontiers in Immunology, 15, 1383612. (doi: 10.3389/fimmu.2024.1383612) (PMID:38742107) (PMCID:PMC11089223)

Furnon, Wilhelm ORCID logoORCID: https://orcid.org/0000-0002-5588-4232, Cowton, Vanessa, De Lorenzo, Giuditta ORCID logoORCID: https://orcid.org/0000-0002-2736-8740, Patel, Arvind ORCID logoORCID: https://orcid.org/0000-0003-4600-2047 and Palmarini, Massimo ORCID logoORCID: https://orcid.org/0000-0001-7007-4070 (2024) Evolution of enhanced innate immune suppression by SARS-CoV-2 Omicron subvariants. Nature Microbiology, 9, pp. 451-463. (doi: 10.1038/s41564-023-01588-4) (PMID:38228858) (PMCID:PMC10847042)

Meehan, G. R. et al. (2023) Phenotyping the virulence of SARS-CoV-2 variants in hamsters by digital pathology and machine learning. PLoS Pathogens, 19(11), e1011589. (doi: 10.1371/journal.ppat.1011589) (PMID:37934791) (PMCID:PMC10656012)

Bouhaddou, M. et al. (2023) SARS-CoV-2 variants evolve convergent strategies to remodel the host response. Cell, 186(21), pp. 4597-4614. (doi: 10.1016/j.cell.2023.08.026) (PMID:37738970) (PMCID:PMC10604369)

Lista, M. J. et al. (2022) The P681H mutation in the spike glycoprotein of the alpha variant of SARS-CoV-2 escapes IFITM restriction and is necessary for type I interferon resistance. Journal of Virology, 96(23), e0125022. (doi: 10.1128/jvi.01250-22) (PMID:36350154) (PMCID:PMC9749455)

Willett, B. J. et al. (2022) Publisher Correction: SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway. Nature Microbiology, 7, 1709. (doi: 10.1038/s41564-022-01241-6) (PMID:36114232) (PMCID:PMC9483304)

Willett, B. J. et al. (2022) SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway. Nature Microbiology, 7(8), pp. 1161-1179. (doi: 10.1038/s41564-022-01143-7) (PMID:35798890) (PMCID:PMC9352574)

Cowton, Vanessa M., Dunlop, James I., Cole, Sarah J., Swann, Rachael E. ORCID logoORCID: https://orcid.org/0000-0002-3945-2253 and Patel, Arvind H. ORCID logoORCID: https://orcid.org/0000-0003-4600-2047 (2022) The neutralizing antibody responses of individuals that spontaneously resolve hepatitis C virus infection. Viruses, 14(7), 1391. (doi: 10.3390/v14071391) (PMID:35891372) (PMCID:PMC9318067)

Zhou, J. et al. (2022) Mutations that adapt SARS-CoV-2 to mink or ferret do not increase fitness in the human airway. Cell Reports, 38(6), 110344. (doi: 10.1016/j.celrep.2022.110344) (PMID:35093235) (PMCID:PMC8768428)

Salas, J. H. et al. (2022) An antigenically diverse, representative panel of envelope glycoproteins for HCV vaccine development. Gastroenterology, 162(2), pp. 562-574. (doi: 10.1053/j.gastro.2021.10.005) (PMID:34655573) (PMCID:PMC8792218)

Meuleman, Theodorus J., Cowton, Vanessa M., Patel, Arvind H. ORCID logoORCID: https://orcid.org/0000-0003-4600-2047 and Liskamp, Robert M.J. ORCID logoORCID: https://orcid.org/0000-0001-8897-8975 (2021) Design and synthesis of HCV-E2 glycoprotein epitope mimics in the molecular construction of potential as synthetic vaccines. Viruses, 13(2), 326. (doi: 10.3390/v13020326) (PMID:33672697) (PMCID:PMC7924389)

Rihn, S. J. et al. (2021) A plasmid DNA-launched SARS-CoV-2 reverse genetics system and coronavirus toolkit for COVID-19 research. PLoS Biology, 19(2), e3001091. (doi: 10.1371/journal.pbio.3001091) (PMID:33630831) (PMCID:PMC7906417)

Cowton, V. M. et al. (2021) Development of a structural epitope mimic: an idiotypic approach to HCV vaccine design. npj Vaccines, 6, 7. (doi: 10.1038/s41541-020-00269-1) (PMID:33420102) (PMCID:PMC7794244)

Meuleman, Theodorus J., Cowton, Vanessa M., Patel, Arvind H. ORCID logoORCID: https://orcid.org/0000-0003-4600-2047 and Liskamp, Rob M.J. ORCID logoORCID: https://orcid.org/0000-0001-8897-8975 (2020) Improving the aqueous solubility of HCV-E2 glycoprotein epitope mimics by cyclization using polar hinges. Journal of Peptide Science, 26(1), e3222. (doi: 10.1002/psc.3222) (PMID:31984607)

Ansari, M. A. et al. (2019) Interferon lambda 4 impacts the genetic diversity of hepatitis C virus. eLife, 8, e42463. (doi: 10.7554/eLife.42463) (PMID:31478835) (PMCID:PMC6721795)

Cowton, Vanessa M., Singer, Joshua B., Gifford, Robert J. ORCID logoORCID: https://orcid.org/0000-0003-4028-9884 and Patel, Arvind H. ORCID logoORCID: https://orcid.org/0000-0003-4600-2047 (2018) Predicting the effectiveness of hepatitis C virus neutralizing antibodies by bioinformatic analysis of conserved epitope residues using public sequence data. Frontiers in Immunology, 9, 1470. (doi: 10.3389/fimmu.2018.01470) (PMID:30013555) (PMCID:PMC6036255)

Naiyer, M. M. et al. (2017) KIR2DS2 recognizes conserved peptides derived from viral helicases in the context of HLA-C. Science Immunology, 2(15), eaal5296. (doi: 10.1126/sciimmunol.aal5296) (PMID:28916719)

Cowton, Vanessa M., Angus, Allan G.N., Cole, Sarah J., Markopoulou, Christina K., Owsianka, Ania, Dunlop, James I., Gardner, Deborah, Krey, Thomas and Patel, Arvind H. ORCID logoORCID: https://orcid.org/0000-0003-4600-2047 (2016) Role of conserved E2 residue W420 in receptor binding and hepatitis C virus infection. Journal of Virology, 90(16), pp. 7456-7468. (doi: 10.1128/JVI.00685-16) (PMID:27279607) (PMCID:PMC4984626)

Swann, Rachael E. ORCID logoORCID: https://orcid.org/0000-0002-3945-2253, Cowton, Vanessa M., Robinson, Mark W., Cole, Sarah J., Barclay, Stephen T., Mills, Peter R., Thomson, Emma C. ORCID logoORCID: https://orcid.org/0000-0003-1482-0889, McLauchlan, John ORCID logoORCID: https://orcid.org/0000-0003-2217-9948 and Patel, Arvind ORCID logoORCID: https://orcid.org/0000-0003-4600-2047 (2016) Broad anti-hepatitis C virus (HCV) antibody responses are associated with improved clinical disease parameters in chronic HCV infection. Journal of Virology, 90(9), pp. 4530-4543. (doi: 10.1128/JVI.02669-15) (PMID:26912610) (PMCID:PMC4836347)

Dunlop, James, Owsianka, Anna, Cowton, Vanessa and Patel, Arvind ORCID logoORCID: https://orcid.org/0000-0003-4600-2047 (2015) Current and future prophylactic vaccines for hepatitis C virus. Vaccine: Development and Therapy, 2015(5), pp. 31-44. (doi: 10.2147/VDT.S48437)

This list was generated on Mon Jun 16 02:04:53 2025 BST.

Research datasets

Jump to: 2024 | 2023
Number of items: 2.

2024

Furnon, W. , Cowton, V. M., De Lorenzo, G. , Orton, R. , Herder, V. , Cantoni, D. , Ilia, G., Correa Mendonca, D. , Kerr, K., Allan, J., Upfold, N. , Meehan, G. R. , Bakshi, S., Das, U. R., Molina Arias, S., McElwee, M., Little, S., Logan, N., Kwok, K. , Smollett, K. , Willett, B. , Da Silva Filipe, A. , Robertson, D. L. , Grove, J. , Patel, A. H. and Palmarini, M. (2024) Phenotypic evolution of SARS-CoV-2 spike throughout the COVID-19 pandemic. [Data Collection]

2023

Meehan, G. , Herder, V. , Allan, J., Huang, X., Kerr, K., Correa Mendonca, D. , Ilia, G., Wright, D. , Nomikou, K., Gu, Q. , Molina Arias, S., Hansmann, F., Hardas, A., Attipa, C., De Lorenzo, G. , Cowton, V., Upfold, N. , Palmalux, N., Brown, J., Barclay, W., Da Silva Filipe, A. , Furnon, W. , Patel, A. and Palmarini, M. (2023) Phenotyping the virulence of SARS-CoV-2 variants in hamsters by digital pathology and machine learning. [Data Collection]

This list was generated on Mon Jun 16 02:04:55 2025 BST.